UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors

Clinical cancer research, 2018-01, Vol.24 (1), p.43-51

2018

Volltextzugriff (PDF)

Challenges in the development of an autologous heat shock protein based anti-tumor vaccine

Human vaccines & immunotherapeutics, 2012-08, Vol.8 (8), p.1152-1155

2012

Volltextzugriff (PDF)

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma a randomized, double-blind, multicenter, comparative trial

Cancer, 2003-10, Vol.98 (8), p.1735-1744

2003

Volltextzugriff (PDF)

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Journal of clinical oncology, 1999-03, Vol.17 (3), p.846-854

1999

Volltextzugriff (PDF)

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

The New England journal of medicine, 1996-12, Vol.335 (24), p.1785-1792

1996

Volltextzugriff (PDF)

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

The New England journal of medicine, 1996-02, Vol.334 (8), p.488-493

1996

Volltextzugriff (PDF)

Alternative statistical strategies for biosimilar drug development

GaBI Journal, 2014-03, Vol.3 (1), p.13-20

2014

Volltextzugriff (PDF)

Managing combination immunotherapy trials from a contract research organization's (CRO's) perspective

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.19-19

2019

Volltextzugriff (PDF)

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases long term follow-up of two randomized, placebo-controlled trials

Cancer, 2000-03, Vol.88 (5), p.1082-1090

2000

Volltextzugriff (PDF)

Adult participation in oncology clinical trials by indication, race, and age

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e17586-e17586

2013

Volltextzugriff (PDF)

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2038-2044

1998

Volltextzugriff (PDF)

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events

Journal of clinical oncology, 1998-02, Vol.16 (2), p.593-602

1998

Volltextzugriff (PDF)

Highlighting the challenge of delayed overall survival (OS) curve separation in immunotherapy clinical trials

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3009-3009

2013

Volltextzugriff (PDF)

HER2+ gastric cancer patient demographics and implications for clinical trial enrollment

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e12526-e12526

2014

Volltextzugriff (PDF)

Uptake of BRAF and ALK mutation screening versus HER2 overexpression testing

Journal of clinical oncology, 2012-10, Vol.30 (30_suppl), p.101-101

2012

Volltextzugriff (PDF)

Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

Cancer, 2003-01, Vol.98 (8), p.1735-1744

2003

Volltextzugriff (PDF)

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

Cancer, 2000-03, Vol.88 (5), p.1082-1090

2000

Volltextzugriff (PDF)

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, phase III, double-blind, placebo-controlled trial

Cancer, 2004-06, Vol.100 (12), p.2613-2621

2004

Volltextzugriff (PDF)

Validation of the Dutch version of the 22-item Sino-Nasal Outcome Test (SNOT-22)

Rhinology (Amsterdam), 2022-09, Vol.5 (5), p.128-132

2022

Volltextzugriff (PDF)

Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial

Critical care (London, England), 2010-01, Vol.14 (3), p.R97-R97, Article R97

2010

Volltextzugriff (PDF)

Diastolic time fraction as a determinant of subendocardial perfusion

American journal of physiology. Heart and circulatory physiology, 2005-05, Vol.288 (5), p.H2450-H2456

2005

Volltextzugriff (PDF)

Clinical Predictors of Ongoing Infection in Secondary Peritonitis: Systematic Review

World journal of surgery, 2006-12, Vol.30 (12), p.2170-2181

2006

Volltextzugriff (PDF)

Has mortality from sepsis improved and what to expect from new treatment modalities: review of current insights

Surgical infections, 2009-08, Vol.10 (4), p.339-348

2009

Volltextzugriff (PDF)

Methods for Evaluating Medical Tests and Biomarkers: Birmingham, UK. 19–20 July 2016

Diagnostic and prognostic research, 2017-02, Vol.1 (S1), Article 7

2017

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors

Challenges in the development of an autologous heat shock protein based anti-tumor vaccine

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma a randomized, double-blind, multicenter, comparative trial

Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

Alternative statistical strategies for biosimilar drug development

Managing combination immunotherapy trials from a contract research organization's (CRO's) perspective

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases long term follow-up of two randomized, placebo-controlled trials

Adult participation in oncology clinical trials by indication, race, and age

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events

Highlighting the challenge of delayed overall survival (OS) curve separation in immunotherapy clinical trials

HER2+ gastric cancer patient demographics and implications for clinical trial enrollment

Uptake of BRAF and ALK mutation screening versus HER2 overexpression testing

Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

RELEASE-HF study: a protocol for an observational, registry-based study on the effectiveness of telemedicine in heart failure in the Netherlands

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, phase III, double-blind, placebo-controlled trial

Validation of the Dutch version of the 22-item Sino-Nasal Outcome Test (SNOT-22)

Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial

Diastolic time fraction as a determinant of subendocardial perfusion

Clinical Predictors of Ongoing Infection in Secondary Peritonitis: Systematic Review

Has mortality from sepsis improved and what to expect from new treatment modalities: review of current insights

Methods for Evaluating Medical Tests and Biomarkers: Birmingham, UK. 19–20 July 2016

Aktive Filter

Suchergebnisse filtern